المؤلفون: Kamel Laribi, Xavier Leleu, Nathalie Texier, Raphaël Germain, Cyrille Touzeau, Mohammad Hammoud, Alexandre Payssot, Samantha Schulmann, Ronan Le Calloch, Adrien Trebouet, Driss Chaoui, Selva David, Omar Benbrahim, Riad Benramdane, Anne Charvet‐Rumpler, Christelle Jadeau, Eglantine Rouanet, Olivier Decaux, Aurore Perrot

المصدر: eJHaem, Vol 5, Iss 1, Pp 55-60 (2024)

مصطلحات موضوعية: carfilzomib, effectiveness, real‐life evidence, refractory relapsing multiple myeloma, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2688-6146Test

الوصول الحر: https://doaj.org/article/c3f39a7eb9244d69938d40f26e158d2bTest

المؤلفون: Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M

المصدر: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2525-2536 (2023)

مصطلحات موضوعية: hidradenitis suppurativa, anti-il23, guselkumab, tildrakizumab, risankizumab, real life evidence, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/guselkumab-risankizumab-and-tildrakizumab-in-the-management-of-hidrade-peer-reviewed-fulltext-article-CCIDTest; https://doaj.org/toc/1178-7015Test

الوصول الحر: https://doaj.org/article/da30fb890f9c4a88a3277c544bdb9c20Test

المؤلفون: Martora F, Megna M, Battista T, Potestio L, Annunziata MC, Marasca C, Villani A, Fabbrocini G

المصدر: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 135-148 (2023)

مصطلحات موضوعية: hidradenitis suppurativa, adalimumab, ustekinumab, secukinumab, ixekizumab, guselkumab, real life evidence, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/adalimumab-ustekinumab-and-secukinumab-in-the-management-of-hidradenit-peer-reviewed-fulltext-article-CCIDTest; https://doaj.org/toc/1178-7015Test

الوصول الحر: https://doaj.org/article/57a3cddc67344d198accd569d8523897Test

المؤلفون: Molinier, O., Besse, B., Barlesi, F., Audigier-Valette, C., Friard, S., Monnet, I., Jeannin, G., Mazières, J., Cadranel, J., Hureaux, J., Hilgers, W., Quoix, E., Coudert, B., Moro-Sibilot, D., Fauchon, E., Westeel, V., Brun, P., Langlais, A., Morin, F., Souquet, P.J., Girard, N.

المساهمون: Centre Hospitalier Le Mans (CH Le Mans), Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, Hôpital Foch Suresnes, Centre Hospitalier Intercommunal de Créteil (CHIC), CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Tenon AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Groupe de recherche clinique Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules (GRC 4 - Theranoscan), Sorbonne Université (SU), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Institut Sainte Catherine Avignon, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Département d'oncologie médicale Centre Georges-François Leclerc, Centre Régional de Lutte contre le cancer Georges-François Leclerc Dijon (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER, Centre Hospitalier Universitaire CHU Grenoble (CHUGA), Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier de Valence, Intergroupe Francophone de Cancérologie Thoracique Paris (IFCT), Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL), Institut Curie Paris

المصدر: ISSN: 2059-7029 ; ESMO Open ; https://hal.sorbonne-universite.fr/hal-03512207Test ; ESMO Open, 2022, 7 (1), pp.100353. ⟨10.1016/j.esmoop.2021.100353⟩.

مصطلحات موضوعية: non-small-cell lung cancer, immunotherapy, sequence, real-life evidence, chemotherapy, lung cancer, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

العلاقة: hal-03512207; https://hal.sorbonne-universite.fr/hal-03512207Test; https://hal.sorbonne-universite.fr/hal-03512207/documentTest; https://hal.sorbonne-universite.fr/hal-03512207/file/1-s2.0-S205970292100315X-main.pdfTest

الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100353Test
https://hal.sorbonne-universite.fr/hal-03512207Test
https://hal.sorbonne-universite.fr/hal-03512207/documentTest
https://hal.sorbonne-universite.fr/hal-03512207/file/1-s2.0-S205970292100315X-main.pdfTest

المؤلفون: Ilkay Koca Kalkan, Hale Ates, Kurtulus Aksu, Selma Yesilkaya, Musa Topel, Dilek Cuhadar Ercelebi, Suleyman Turkyilmaz, Ali Oncul, Senay Demir

المصدر: World Allergy Organization Journal, Vol 14, Iss 7, Pp 100558- (2021)

مصطلحات موضوعية: Adherence, Allergen immunotherapy, COVID-19, Real-life evidence, Subcutaneous immunotherapy, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S1939455121000521Test; https://doaj.org/toc/1939-4551Test

الوصول الحر: https://doaj.org/article/e30e714e36cd4c038b301db0b9119e20Test

المؤلفون: Ornello R., Ahmed F., Negro A., Miscio A. M., Santoro A., Alpuente A., Russo A., Silvestro M., Cevoli S., Brunelli N., Vernieri F., Grazzi L., Baraldi C., Guerzoni S., Andreou A. P., Lambru G., Frattale I., Kamm K., Ruscheweyh R., Russo M., Torelli P., Filatova E., Latysheva N., Gryglas-Dworak A., Straburzynski M., Butera C., Colombo B., Filippi M., Pozo-Rosich P., Martelletti P., Sacco S.

المساهمون: Ornello, R., Ahmed, F., Negro, A., Miscio, A. M., Santoro, A., Alpuente, A., Russo, A., Silvestro, M., Cevoli, S., Brunelli, N., Vernieri, F., Grazzi, L., Baraldi, C., Guerzoni, S., Andreou, A. P., Lambru, G., Frattale, I., Kamm, K., Ruscheweyh, R., Russo, M., Torelli, P., Filatova, E., Latysheva, N., Gryglas-Dworak, A., Straburzynski, M., Butera, C., Colombo, B., Filippi, M., Pozo-Rosich, P., Martelletti, P., Sacco, S.

مصطلحات موضوعية: chronic migraine, multicenter study, onabotulinumtoxinA, real-life evidence

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33778933; info:eu-repo/semantics/altIdentifier/wos/WOS:000634303600001; volume:10; issue:1; firstpage:637; lastpage:650; numberofpages:14; journal:PAIN AND THERAPY; http://hdl.handle.net/11573/1579089Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103373254

الإتاحة: https://doi.org/10.1007/s40122-021-00253-0Test
http://hdl.handle.net/11573/1579089Test

المؤلفون: Ornello, Raffaele, Ahmed, Fayyaz, Negro, Andrea, Miscio, Anna Maria, Santoro, Antonio, Alpuente, Alicia, Russo, Antonio, Silvestro, Marcello, Cevoli, Sabina, Brunelli, Nicoletta, Vernieri, Fabrizio, Grazzi, Licia, Baraldi, Carlo, Guerzoni, Simona, Andreou, Anna P., Lambru, Giorgio, Frattale, Ilaria, Kamm, Katharina, Ruscheweyh, Ruth, Russo, Marco, Torelli, Paola, Filatova, Elena, Latysheva, Nina, Gryglas-Dworak, Anna, Straburzynski, Marcin, Butera, Calogera, Colombo, Bruno, Filippi, Massimo, Pozo-Rosich, Patricia, Martelletti, Paolo, Sacco, Simona, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Chronic migraine, Multicenter study, OnabotulinumtoxinA, Real-life evidence

وصف الملف: application/pdf

العلاقة: Pain and Therapy; Vol. 10 (march 2021), p. 637-650; https://ddd.uab.cat/record/240760Test; urn:10.1007/s40122-021-00253-0; urn:oai:ddd.uab.cat:240760; urn:pmcid:PMC8119503; urn:pmc-uid:8119503; urn:pmid:33778933; urn:articleid:2193651Xv10p637; urn:oai:pubmedcentral.nih.gov:8119503

الإتاحة: https://ddd.uab.cat/record/240760Test

المؤلفون: Francesco Cinetto (8638674), Raffaella Neri (10231554), Fabrizio Vianello (8638671), Andrea Visentin (10231557), Gregorio Barilà (10231560), Sabrina Gianese (10231563), Alison Lanciarotta (10231566), Cinzia Milito (8262396), Marcello Rattazzi (2254951), Francesco Piazza (378885), Livio Trentin (317624), Renato Zambello (317614), Carlo Agostini (8738), Riccardo Scarpa (7586054)

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Hematology, Infectious Diseases, Virology, IVIG, 102 PAD patients, Subcutaneous immunoglobulins replac., deficiency, Multiple Myeloma patients, Non-Hodgkin Lymphoma patients, Chronic Lymphocytic Leukemia, evidence-based data, antibody deficiencies, 131 SAD patients, immunoglobulin replacement therapy, SAD patients, B cell recovery, Real life evidence, SCIG

العلاقة: https://figshare.com/articles/journal_contribution/Ig_before_SCIG_and_comorbidities_in_the_SAD_cohort_/14163240Test

الإتاحة: https://doi.org/10.1371/journal.pone.0247717.s005Test

المؤلفون: Francesco Cinetto (8638674), Raffaella Neri (10231554), Fabrizio Vianello (8638671), Andrea Visentin (10231557), Gregorio Barilà (10231560), Sabrina Gianese (10231563), Alison Lanciarotta (10231566), Cinzia Milito (8262396), Marcello Rattazzi (2254951), Francesco Piazza (378885), Livio Trentin (317624), Renato Zambello (317614), Carlo Agostini (8738), Riccardo Scarpa (7586054)

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Hematology, Infectious Diseases, Virology, IVIG, 102 PAD patients, Subcutaneous immunoglobulins replac., deficiency, Multiple Myeloma patients, Non-Hodgkin Lymphoma patients, Chronic Lymphocytic Leukemia, evidence-based data, antibody deficiencies, 131 SAD patients, immunoglobulin replacement therapy, SAD patients, B cell recovery, Real life evidence, SCIG

العلاقة: https://figshare.com/articles/journal_contribution/Ig_before_and_during_SCIG_in_PAD_and_SAD_/14163243Test

الإتاحة: https://doi.org/10.1371/journal.pone.0247717.s006Test

المؤلفون: Martora, Fabrizio, Scalvenzi, Massimiliano, Battista, Teresa, Fornaro, Luigi, Potestio, Luca, Ruggiero, Angelo, Megna, Matteo

المساهمون: Martora, Fabrizio, Scalvenzi, Massimiliano, Battista, Teresa, Fornaro, Luigi, Potestio, Luca, Ruggiero, Angelo, Megna, Matteo

مصطلحات موضوعية: anti-IL23, guselkumab, hidradenitis suppurativa, real life evidence, risankizumab, tildrakizumab

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001090734800001; volume:16; firstpage:2525; lastpage:2536; numberofpages:12; journal:CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY; https://hdl.handle.net/11588/939843Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85172407646

الإتاحة: https://doi.org/10.2147/CCID.S418748Test
https://hdl.handle.net/11588/939843Test